PER
Click for more information
0.00% 6.7¢ percheron therapeutics limited

Combined Therapies for DMD, page-98

  1. MisterMister
    572 Posts.
    lightbulb Created with Sketch. 55
    clock Created with Sketch.
    16/11/19
    11:07
    Post #: 41461249
    Compared to control? Do you actually think any trial involving children (with this disease in particular) would pass ethics approval giving kids who need treatment a placebo? Did the Sarepta approval require a control?
    ANP Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

WGX Westgold sets its sights on top five producer status through merger with Karora
right-arrow Created with Sketch.
SS1 Sun Silver hits silver grades above 200g/t in early-stage portable scanner analysis
right-arrow Created with Sketch.
VMS Venture to sniff out high-grade REE targets at Jupiter project, WA
right-arrow Created with Sketch.
NEWS Is oil undervalued?
right-arrow Created with Sketch.
GRX GreenX picks up prospective copper project in Germany
right-arrow Created with Sketch.
DVP Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
6.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $57.69M
Open High Low Value Volume
6.5¢ 6.7¢ 6.3¢ $30.83K 473.0K

Buyers (Bids)

No. Vol. Price($)
2 27948 6.5¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 23682 2
View Market Depth
Last trade - 11.30am 06/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.